Dr. Mary Mccormack

• Dr. Mary McCormack’s is Experienced Clinical Oncologist specializing in gynaecological and breast cancers, including womb, cervix, uterus, ovary, vagina, and vulva.
• Her Sub-specialist interests in cervical cancer treatments and targeted therapies for breast, endometrial, and ovarian cancers.
• She Provides treatments including chemotherapy, radiotherapy, targeted/biological therapy, and brachytherapy.
• She completed her Medical degree from Guy’s and St Thomas’ Hospital; PhD in Radiation Biology (1989); FRCR Clinical Oncology (2000).
• She is a Consultant at University College London Hospitals (UCLH) since 2002.
• Dr. Mary McCormack is a Chair of the Cervical Cancer Research Network (CCRN) and executive member of the Gynaecologic Cancer Intergroup (GCIG).
• She is also Member of IGCS Education Committee and ASCO International Affairs Committee.
• Dr. Mary Chief Investigator in numerous national and international clinical trials.
• She has Authored multiple peer-reviewed publications and active in clinical education and research presentations.

Conditions treated by Dr. Mary Mccormack

• Brachytherapy
• Cervical Cancer
• Breast Cancer
• Gynaecological Cancers
• uterine cancer
• vaginal and vulval cancer
• Ovary cancer
• Chemotherapy
• Biological therapy
• Radiotherapy

Area of Interest

• Clinical Oncology
• Medical Oncology

Qualification

• MBBS: Graduated from Guy’s and St Thomas’s Hospital, London, in 1993
• PhD in Radiation Biology: Awarded in 1989
• FRCR (Clinical Oncology): Achieved in 2000

Work Experiences

• Consultant Clinical Oncologist at University College London Hospitals (UCLH): Appointed in 2002
• Senior Clinical Oncologist for Gynaecological Cancer at UCLH: Leads referrals across the North London Cancer Network